40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
26.51%
Revenue growth exceeding 1.5x CRK's 15.19%. David Dodd would verify if faster growth reflects superior business model.
55.07%
Cost growth above 1.5x CRK's 17.40%. Michael Burry would check for structural cost disadvantages.
4.70%
Gross profit growth below 50% of CRK's 14.42%. Michael Burry would check for structural issues.
-17.24%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.81%
Other expenses growth less than half of CRK's 36.54%. David Dodd would verify if advantage is sustainable.
11.04%
Operating expenses growth less than half of CRK's 31.34%. David Dodd would verify sustainability.
39.69%
Total costs growth above 1.5x CRK's 25.88%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
10.34%
Similar D&A growth to CRK's 13.44%. Walter Schloss would investigate industry patterns.
3.96%
Similar EBITDA growth to CRK's 4.79%. Walter Schloss would investigate industry trends.
-16.82%
Both companies show margin pressure. Martin Whitman would check industry conditions.
32.40%
Operating income growth exceeding 1.5x CRK's 16.79%. David Dodd would verify competitive advantages.
4.65%
Operating margin growth exceeding 1.5x CRK's 1.39%. David Dodd would verify competitive advantages.
-7178.76%
Other expenses reduction while CRK shows 6.12% growth. Joel Greenblatt would examine advantage.
-32.52%
Pre-tax income decline while CRK shows 24.07% growth. Joel Greenblatt would examine position.
-46.66%
Pre-tax margin decline while CRK shows 7.71% growth. Joel Greenblatt would examine position.
-50.22%
Tax expense reduction while CRK shows 18.67% growth. Joel Greenblatt would examine advantage.
-24.51%
Net income decline while CRK shows 49.29% growth. Joel Greenblatt would examine position.
-40.33%
Net margin decline while CRK shows 29.60% growth. Joel Greenblatt would examine position.
-10.71%
EPS decline while CRK shows 49.48% growth. Joel Greenblatt would examine position.
-12.09%
Diluted EPS decline while CRK shows 44.33% growth. Joel Greenblatt would examine position.
-1.87%
Share count reduction while CRK shows 2.04% change. Joel Greenblatt would examine strategy.
-0.44%
Diluted share reduction while CRK shows 2.02% change. Joel Greenblatt would examine strategy.